{"id":"CHEMBL1076544","canonicalSmiles":"O=C(Nc1ccccc1-c1ccc(Cl)cc1)c1cccnc1Cl","inchiKey":"WYEMLYFITZORAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BOSCALID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAS 510 F","Boscalid","Endura"],"crossReferences":{"PubChem":["144214006","26757126","29216431"],"drugbank":["DB12792"],"chEBI":["81822"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1110","canonicalSmiles":"Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O","inchiKey":"JSWZEAMFRNKZNL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALOSETRON","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["A03AE01","Alosetron","Lotronex"],"crossReferences":{"DailyMed":["alosetron%20hydrochloride"],"Wikipedia":["Alosetron"],"drugbank":["DB00969"],"chEBI":["253342"]},"childChemblIds":["CHEMBL1200885"],"count":2,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["EFO_0010282","EFO_0000555"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for gastrointestinal disease and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL112302","canonicalSmiles":"O=[Se]([O-])[O-].[Na+].[Na+]","inchiKey":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM SELENITE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2009089","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sodium Selenite","Sodium selenite"],"crossReferences":{"DrugCentral":["4782"],"PubChem":["144210175"],"Wikipedia":["Sodium_selenite"],"chEBI":["48843"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1161861","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1OP(=O)(O)O","inchiKey":"AEOBEOJCBAYXBA-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Adenosine 2',5'-Diphosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adenosine 2',5'-Diphosphate"],"crossReferences":{"drugbank":["DB02098"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL116597","canonicalSmiles":"N[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCc1ccccc1","inchiKey":"MEPJWLFTTFHOQO-MOPGFXCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL116597","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07143"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL116736","canonicalSmiles":"O=CO","inchiKey":"BDAGIHXWWSANSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E236"],"crossReferences":{"Wikipedia":["Formic_acid"],"drugbank":["DB01942"],"chEBI":["30751"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1173328","canonicalSmiles":"Cc1cccc(O)c1O","inchiKey":"PGSWEKYNAOWQDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Methylcatechol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Methylcatechol"],"crossReferences":{"drugbank":["DB03454"],"chEBI":["18404"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL119385","canonicalSmiles":"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl","inchiKey":"VEPKQEUBKLEPRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEFLAMAPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["745","Neflamapimod","VD-31","VD-31,745","VD-31745","VRT-031745","VX-745","Vx-745"],"crossReferences":{"PubChem":["103905630","124950172","174006470","50100122"],"drugbank":["DB07138"],"chEBI":["90528"]},"count":4,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["Orphanet_399","HP_0100543","HP_0000726","EFO_0000249"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1194325","canonicalSmiles":"O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1","inchiKey":"ASMXXROZKSBQIH-VITNCHFBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACLIDINIUM","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aclidinium"],"crossReferences":{"DailyMed":["aclidinium%20bromide"],"drugbank":["DB08897"],"chEBI":["65346"]},"childChemblIds":["CHEMBL551466"],"count":1,"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0000270","EFO_0000464","EFO_0006505","EFO_0003768","EFO_0000341"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2012 and has 1 investigational indication."}
{"id":"CHEMBL1200400","canonicalSmiles":"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[n-]c12.[Na+]","inchiKey":"WISNYKIQFMKSDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AZATHIOPRINE SODIUM","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1542","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azathioprine sodium","Imuran"],"synonyms":["Azathioprine sodium","Azathioprine sodium salt"],"crossReferences":{"DailyMed":["azathioprine%20sodium"]},"linkedTargets":{"rows":["ENSG00000128059"],"count":1},"linkedDiseases":{"rows":["EFO_0000384"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200558","canonicalSmiles":"CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1","inchiKey":"CLKOFPXJLQSYAH-ABRJDSQDSA-N","drugType":"Protein","blackBoxWarning":true,"name":"BACITRACIN","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Albac 50","Baci-rx","Baciferm 50","Baciguent","Baciim","Bacitracin"],"synonyms":["Bacitracin","E700"],"crossReferences":{"DailyMed":["bacitracin","bacitracin%20zinc"],"DrugCentral":["281"],"Wikipedia":["Bacitracin"],"drugbank":["DB00626"],"chEBI":["35862"]},"childChemblIds":["CHEMBL2096639"],"count":7,"approvedIndications":["EFO_0003106","EFO_0000771","EFO_0000544"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and has 3 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200758","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]","inchiKey":"KLOHDWPABZXLGI-YWUHCJSESA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPICILLIN SODIUM","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL174","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amp Equine","Ampicillin sodium","Omnipen","Omnipen-n","Penbritin","Penbritin-s","Polycillin","Polycillin-n","Principen","Principen-N","Totacillin","Totacillin-n"],"synonyms":["Ampicillin sodium","Ampicillin sodium salt"],"crossReferences":{"DailyMed":["ampicillin%20sodium"],"PubChem":["11533065"],"chEBI":["34535"]},"count":7,"approvedIndications":["EFO_1000831","HP_0100806","EFO_0000544","EFO_0000465"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and has 4 approved and 3 investigational indications."}
{"id":"CHEMBL1200848","canonicalSmiles":"CCCCCC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"DOMWKUIIPQCAJU-LJHIYBGHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYPROGESTERONE CAPROATE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Delalutin","Hydroxyprogesterone caproate","Makena","Makena (autoinjector)","Makena preservative free","Proluton depot"],"synonyms":["Hydroxyprogesterone","Hydroxyprogesterone caproate","NSC-17592","Oxiprogesterone caproate"],"crossReferences":{"DailyMed":["hydroxyprogesterone%20caproate"],"PubChem":["144207051","144212650","170465210","56424128","855528"],"drugbank":["DB06789"],"chEBI":["5812"]},"childChemblIds":["CHEMBL3526451"],"count":2,"approvedIndications":["EFO_0003917"],"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0003917","EFO_0003922","EFO_0002950"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and is indicated for premature birth and has 1 investigational indication."}
{"id":"CHEMBL1200850","canonicalSmiles":"Nc1nc([O-])c2ncn(COC(CO)CO)c2n1.[Na+]","inchiKey":"JJICLMJFIKGAAU-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"GANCICLOVIR SODIUM","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL182","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cytovene","Ganciclovir","Ganciclovir sodium"],"synonyms":["Ganciclovir sodium","Ganciclovir sodium salt","RS-21592 SODIUM"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200966","canonicalSmiles":"Nc1ccc(C(=O)[O-])c(O)c1.[Na+]","inchiKey":"FVVDKUPCWXUVNP-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM AMINOSALICYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1169","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminosalicylate sodium","Sodium Aminosalicylate","Sodium aminosalicylate"],"crossReferences":{"PubChem":["11532911","170465206","26747852"],"chEBI":["2661"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1201000","canonicalSmiles":"O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)[N-]1.[Na+]","inchiKey":"AFDJQFFKYDCYIG-JSGFVSQVSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"NITROFURANTOIN SODIUM","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL572","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ivadantin"],"synonyms":["Nitrofurantoin sodium"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1201051","canonicalSmiles":"CN/C(=N\\CCSCc1nc[nH]c1C)NC#N.Cl","inchiKey":"QJHCNBWLPSXHBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIMETIDINE HYDROCHLORIDE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL30","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cimetidine hydrochloride","Tagamet"],"synonyms":["Cimetidine hydrochloride"],"crossReferences":{"chEBI":["50362"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977."}
{"id":"CHEMBL1201186","drugType":"Small molecule","blackBoxWarning":false,"name":"BISMUTH SUBCITRATE POTASSIUM","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["1001277","Bismuth subcitrate","Bismuth subcitrate potassium"],"crossReferences":{"DailyMed":["bismuth%20subcitrate%20potassium"],"DrugCentral":["4355"]},"count":6,"approvedIndications":["EFO_0003948","HP_0004398","EFO_0000544","EFO_0004607"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL1201245","canonicalSmiles":"CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1","inchiKey":"NUNIWXHYABYXKF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMODIPHENHYDRAMINE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bromazine","Bromodiphenhydramine"],"crossReferences":{"PubChem":["170465292"],"Wikipedia":["Bromazine"],"drugbank":["DB01237"],"chEBI":["59177"]},"childChemblIds":["CHEMBL1200967"],"count":1,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003785"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954 and is indicated for allergy."}
{"id":"CHEMBL1201328","canonicalSmiles":"CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2","inchiKey":"XZSMZRXAEFNJCU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARPHENAZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carfenazine","Carphenazine"],"crossReferences":{"PubChem":["50125832"],"Wikipedia":["Carfenazine"],"drugbank":["DB01038"]},"childChemblIds":["CHEMBL2358147"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201421","drugType":"Unknown","blackBoxWarning":false,"name":"PEGAPTANIB SODIUM","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Macugen"],"synonyms":["EYE-001","EYE001","EYEOO1","NX-1838","NX1838","Pegaptanib sodium"],"crossReferences":{"DailyMed":["pegaptanib%20sodium"]},"count":7,"approvedIndications":["EFO_0004683","EFO_0005753"],"linkedTargets":{"rows":["ENSG00000112715"],"count":1},"linkedDiseases":{"rows":["EFO_0009606","Orphanet_892","MONDO_0003005","EFO_0004683","EFO_0001365","EFO_1001157","EFO_0005753","EFO_0009322","EFO_0009321"],"count":9},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for ocular vascular disease and wet macular degeneration and has 5 investigational indications."}
{"id":"CHEMBL1201775","canonicalSmiles":"C[C@H](O)[C@H](O)[C@H]1CNc2[nH]c(N)nc(=O)c2N1.Cl.Cl","inchiKey":"RKSUYBCOVNCALL-NTVURLEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAPROPTERIN DIHYDROCHLORIDE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201774","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kuvan"],"synonyms":["SUN-0588","SUN-0588 (SHIRATORI)","Sapropterin dihydrochloride","Sapropterin hydrochloride","T-1401","T1401","T1401 (BIOMARIN)"],"crossReferences":{"DailyMed":["sapropterin%20dihydrochloride"],"PubChem":["144205335"],"chEBI":["32120"]},"count":9,"approvedIndications":["Orphanet_716","Orphanet_238583"],"linkedTargets":{"rows":["ENSG00000171759"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","Orphanet_716","Orphanet_232","Orphanet_238583","EFO_0003884","EFO_0001645","EFO_0003758","EFO_1001461","EFO_0003876","EFO_0000692","EFO_0005411","EFO_0004265","EFO_0000537"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for hyperphenylalaninemia and phenylketonuria and has 7 investigational indications."}
{"id":"CHEMBL1201865","drugType":"Enzyme","blackBoxWarning":false,"name":"VELAGLUCERASE ALFA","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vpriv"],"synonyms":["EC 3.2.1.45","EC-3.2.1.45","Velaglucerase alfa"],"crossReferences":{"DailyMed":["velaglucerase%20alfa"],"DrugCentral":["4989"],"Wikipedia":["Velaglucerase_alfa"]},"count":1,"approvedIndications":["Orphanet_355"],"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 2010 and is indicated for gaucher disease."}
{"id":"CHEMBL1213467","canonicalSmiles":"OC[C@H]1ONC[C@@H](O)[C@@H]1O","inchiKey":"KHVCOYGKHDJPBZ-WDCZJNDASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAHYDROOXAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03862"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL121810","canonicalSmiles":"CCc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)O[C@@H]1N2C","inchiKey":"ZOBDWFRKFSPCRB-UNMCSNQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GANSTIGMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ganstigmine"],"crossReferences":{"drugbank":["DB06525"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL122264","canonicalSmiles":"c1ccc(Nc2nc(OCC3CCCCC3)c3[nH]cnc3n2)cc1","inchiKey":"XWWRLKIBRPJQJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NU-6094","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NU-6094"],"crossReferences":{"drugbank":["DB06948"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230309","canonicalSmiles":"Cc1c[nH]cn1","inchiKey":"XLSZMDLNRCVEIJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230309","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208246","17389237","49731980"],"drugbank":["DB03385"],"chEBI":["40035"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232589","canonicalSmiles":"CCNC","inchiKey":"LIWAQLJGPBVORC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLETHYLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02396"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235132","canonicalSmiles":"NC(=O)c1cccc([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)n1","inchiKey":"LFERELMXERXKKQ-KMXXXSRASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235132","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04071"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235810","canonicalSmiles":"Cc1nc2cc3nc(N)[nH]c(=O)c3cc2[nH]1","inchiKey":"PLJNUNPYZVVIRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235810","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08511"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236970","canonicalSmiles":"[Zn+2]","inchiKey":"PTFCDOFLOPIGGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZINC ION","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zinc ion"],"crossReferences":{"drugbank":["DB14532"],"chEBI":["29105"]},"count":20,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 20 investigational indications."}
{"id":"CHEMBL1252","canonicalSmiles":"CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O","inchiKey":"AIWRTTMUVOZGPW-HSPKUQOVSA-N","drugType":"Protein","blackBoxWarning":true,"name":"ABARELIX","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Plenaxis"],"synonyms":["Abarelix","PPI-149","Plenaxis","R-382","R-3827","R382","R3827"],"crossReferences":{"Wikipedia":["Abarelix"],"drugbank":["DB00106"],"chEBI":["337298"]},"count":2,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0008315"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for neoplasm and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1256847","canonicalSmiles":"Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21.[I-].[I-]","inchiKey":"BTXPITUAZUILEM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1256847","maximumClinicalTrialPhase":0,"parentId":"CHEMBL333826","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL126","canonicalSmiles":"CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1","inchiKey":"TYZROVQLWOKYKF-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINEZOLID","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Linezolid","Zyvox"],"synonyms":["Linezolid","U-100,766","U-100766","Zyvox"],"crossReferences":{"DailyMed":["linezolid"],"PubChem":["144205799","26719842","49681612"],"Wikipedia":["Linezolid"],"drugbank":["DB00601"],"chEBI":["63607"]},"count":19,"approvedIndications":["EFO_0003106","EFO_0000771","EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 3 approved and 16 investigational indications."}
{"id":"CHEMBL127300","canonicalSmiles":"COc1cc(C(=O)OCCCN(C)CCN(C)CCCOC(=O)c2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC","inchiKey":"KRQAMFQCSAJCRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXOBENDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexobendine"],"crossReferences":{"drugbank":["DB13265"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1342","canonicalSmiles":"O=C(O)CCCO","inchiKey":"SJZRECIVHVDYJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXYBATE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[".gamma.-hydroxybutyrate","Gamma hydroxybutyrate","Gamma-hydroxybutyrate","Oxybate","Xyrem"],"crossReferences":{"DailyMed":["calcium%20oxybate","magnesium%20oxybate","potassium%20oxybate","sodium%20oxybate"],"Wikipedia":["Gamma-Hydroxybutyric_acid"],"drugbank":["DB01440"],"chEBI":["30830"]},"childChemblIds":["CHEMBL1200682","CHEMBL4594393","CHEMBL4594395","CHEMBL4594394"],"linkedTargets":{"rows":["ENSG00000136928","ENSG00000204681"],"count":2},"linkedDiseases":{"rows":["MONDO_0021107","EFO_0005203","EFO_0005687","HP_0001337","EFO_0004777","EFO_0002508","EFO_0000249","EFO_0004698","EFO_0003843","EFO_0000614","EFO_0003829","Orphanet_2131","Orphanet_93961","EFO_0003918","EFO_0003108","EFO_0004540","EFO_0007462"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2002. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1372","canonicalSmiles":"N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O","inchiKey":"YPZRWBKMTBYPTK-BJDJZHNGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXIGLUTATIONE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Glutathione disulfide","Oxiglutatione"],"crossReferences":{"DailyMed":["glutathione%20disulfide"],"PubChem":["144206973","26754399","29215201"],"Wikipedia":["Glutathione_disulfide"],"drugbank":["DB03310"],"chEBI":["17858"]},"count":5,"linkedTargets":{"rows":["ENSG00000104687"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000565","MONDO_0008170","MONDO_0007254","EFO_0003060"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 5 investigational indications."}
{"id":"CHEMBL1372950","canonicalSmiles":"CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13","inchiKey":"YSEXMKHXIOCEJA-FVFQAYNVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICERGOLINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sermion"],"synonyms":["FI-6714","NSC-150531","Nicergoline"],"crossReferences":{"PubChem":["104171344","124882915","144204361","170465878","26751796","50104491"],"drugbank":["DB00699"],"chEBI":["31902"]},"count":5,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 4 investigational indications."}
{"id":"CHEMBL14245","canonicalSmiles":"CCCCO","inchiKey":"LRHPLDYGYMQRHN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYL ALCOHOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butyl alcohol"],"crossReferences":{"PubChem":["144204597","144207939","17388872","17389645"],"Wikipedia":["N-Butanol"],"drugbank":["DB02145"],"chEBI":["28885"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1466172","canonicalSmiles":"Cc1ncc([N+](=O)[O-])n1CCOC(=O)c1ccccc1","inchiKey":"CUUCCLJJOWSASK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METRONIDAZOLE BENZOATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metronidazole benzoate"],"crossReferences":{"PubChem":["17504163"],"chEBI":["50688"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1492500","canonicalSmiles":"CN(C)CC/C=C1\\c2ccccc2CSc2ccccc21","inchiKey":"PHTUQLWOUWZIMZ-GZTJUZNOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOTHIEPIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dosulepin","Dothiepin"],"crossReferences":{"PubChem":["11112454"],"drugbank":["DB09167"],"chEBI":["36803"]},"childChemblIds":["CHEMBL1711280"],"count":1,"approvedIndications":["EFO_0003761"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression."}
{"id":"CHEMBL1502","canonicalSmiles":"COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC","inchiKey":"IQPSEEYGBUAQFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PANTOPRAZOLE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pantoloc control","Protium","Protium i.v."],"synonyms":["BY 1023","BY-1023","Pantoprazole","Protonix","SK&F 96022","SK&F-96022","SK-96022","SKF-96022"],"crossReferences":{"DailyMed":["pantoprazole%20sodium"],"PubChem":["144205030","170466337","174007264","26749082"],"Wikipedia":["Pantoprazole"],"drugbank":["DB00213"],"chEBI":["7915"]},"childChemblIds":["CHEMBL3989559","CHEMBL1200408"],"count":20,"approvedIndications":["EFO_0003948","HP_0004398"],"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["HP_0002239","EFO_0000373","MONDO_0043839","EFO_0003948","HP_0004398","EFO_0000771","EFO_0000337","EFO_0003931","EFO_0007157","EFO_1000961","EFO_0000400","EFO_0000692","EFO_0000616","EFO_0000280","EFO_0001645","HP_0002012","EFO_0007549","EFO_0003843","MONDO_0008315","MONDO_0003523","EFO_1001355","EFO_0008533","EFO_0003885","MP_0001914","EFO_0009454","Orphanet_79292","EFO_0001359","EFO_0001360","HP_0100633","EFO_0005672","EFO_0009544","EFO_0009878"],"count":32},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for gastroesophageal reflux disease and peptic ulcer and has 18 investigational indications."}
{"id":"CHEMBL1523964","canonicalSmiles":"CN[C@@H](C)[C@H](O)c1ccccc1.CN[C@@H](C)[C@H](O)c1ccccc1.O=S(=O)(O)O","inchiKey":"CAVQBDOACNULDN-KHFUBBAMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPHEDRINE SULFATE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL211456","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akovaz","Corphedra","Emerphed","Expansyl","Franol plus","Franol-plus","Isofedrol"],"synonyms":["Ephedrine sulfate","Ephedrine sulphate"],"crossReferences":{"DailyMed":["ephedrine%20sulfate"],"PubChem":["50106282"]},"count":1,"approvedIndications":["EFO_0000270"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2016 and is indicated for asthma."}
{"id":"CHEMBL1625607","canonicalSmiles":"CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1","inchiKey":"FQQIIPAOSKSOJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEBHYDROLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fabahistin","Incidal","Omeril"],"synonyms":["Mebhydrolin","Mebhydrolin napadisylate"],"crossReferences":{"drugbank":["DB13808"]},"childChemblIds":["CHEMBL1714118","CHEMBL1324326","CHEMBL1600878","CHEMBL1394472"],"count":1,"approvedIndications":["EFO_0003785"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for allergy."}
{"id":"CHEMBL1631540","canonicalSmiles":"Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1","inchiKey":"ANGUXJDGJCHGOG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK163090","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK163090","Gsk163090"],"childChemblIds":["CHEMBL3215829"],"count":2,"linkedTargets":{"rows":["ENSG00000108576","ENSG00000135312","ENSG00000178394","ENSG00000179546"],"count":4},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1673408","canonicalSmiles":"CN1CCN(c2ccc(N3C[C@H](CO)OC3=O)cc2F)C=N1","inchiKey":"QLUWQAFDTNAYPN-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELPAZOLID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Delpazolid","LCB-01-0371","LCB-010371","Lcb01-0371"],"crossReferences":{"drugbank":["DB13077"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL172155","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1","inchiKey":"POQDXIFVWVZVML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL172155","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB09182"]},"childChemblIds":["CHEMBL2361433"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1730601","canonicalSmiles":"Oc1cc(O)c(Cl)cn1","inchiKey":"ZPLQIPFOCGIIHV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GIMERACIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gimeracil"],"crossReferences":{"PubChem":["144206214","170466048","50125750"],"drugbank":["DB09257"]},"count":31,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 31 investigational indications."}
{"id":"CHEMBL1743015","drugType":"Antibody","blackBoxWarning":false,"name":"ETROLIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-Beta7","Anti-Beta7 Pro145223","Etrolizumab","PRO-145223","PRO145223","RG-7413","RHUMAB-BETA7","rhuMAb beta7"],"count":2,"linkedTargets":{"rows":["ENSG00000139626"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000384"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743263","canonicalSmiles":"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12","inchiKey":"PBUNVLRHZGSROC-VTIMJTGVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROERGOCRYPTINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha-Dihydroergocriptine"],"crossReferences":{"PubChem":["144206629"],"drugbank":["DB11274"],"chEBI":["59919"]},"childChemblIds":["CHEMBL3707289"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1747","canonicalSmiles":"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O","inchiKey":"NLVFBUXFDBBNBW-PBSUHMDJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOBRAMYCIN","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aktob","Bethkis","Bramitob","Kitabis pak","Nebcin","Nebicin","Nebramycin","Nebris","Obramycin","Tobi","Tobi podhaler","Tobradex","Tobradex St","Tobralex","Tobramycin","Tobravisc","Tobrex","Tymbrineb","Vantobra"],"synonyms":["47663","NSC-180514","Nebcin","Nebramycin factor 6","Tobramycin"],"crossReferences":{"DailyMed":["tobramycin"],"PubChem":["144204177"],"Wikipedia":["Tobramycin","Tobramycin/dexamethasone"],"drugbank":["DB00684"],"chEBI":["28864"]},"childChemblIds":["CHEMBL3764429","CHEMBL1200780","CHEMBL3989564"],"count":17,"approvedIndications":["MP_0001845","EFO_0000771","EFO_0000544","Orphanet_586","EFO_0007141","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 6 approved and 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1851943","canonicalSmiles":"CCCCc1nc2cc(/C=C/C(=O)NO)ccc2n1CCN(CC)CC","inchiKey":"JHDKZFFAIZKUCU-ZRDIBKRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRACINOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pracinostat","SB 939","SB-939"],"crossReferences":{"drugbank":["DB05223"]},"childChemblIds":["CHEMBL3215861"],"count":7,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL185586","canonicalSmiles":"C[C@@](O)(CBr)CCOP(=O)(O)OP(=O)(O)O","inchiKey":"YKAYCWPQDPILSA-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL185586","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02480"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1865135","canonicalSmiles":"COC1CC(=C(c2cccs2)c2cccs2)C[N+](C)(C)C1","inchiKey":"PDYOTUCJOLELJU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIMEPIDIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50125748"],"drugbank":["DB13850"]},"childChemblIds":["CHEMBL2107574"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL187927","canonicalSmiles":"c1cnc2c(c1)O[C@H]1CCN3CC[C@@]1(C2)C3","inchiKey":"SUPRUPHAEXPGPF-QWHCGFSZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIANICLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dianicline","SSR-591813","SSR591813"],"crossReferences":{"drugbank":["DB12125"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL188442","canonicalSmiles":"O=C(O)/C(=C/c1ccc(Oc2ccccc2Br)cc1)NC(=O)c1ccccc1","inchiKey":"WLPJLQNKCJWAFL-RGEXLXHISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL188442","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01720"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1885178","canonicalSmiles":"C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1","inchiKey":"XMSXQFUHVRWGNA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1885178","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144213487","26757398"],"drugbank":["DB11244"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1889140","canonicalSmiles":"CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.Cl","inchiKey":"NDNSIBYYUOEUSV-RSAXXLAASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROPIVACAINE HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1077896","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Narapin","Naropin","Ropivacaine hydrochloride"],"synonyms":["Ropivacaine hydrochloride","Ropivacaine hydrochloride hydrate","Ropivacaine hydrochloride monohydrate"],"crossReferences":{"DailyMed":["ropivacaine%20hydrochloride"],"PubChem":["144205774","170465120","49681555"],"chEBI":["60803"]},"count":5,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000153253","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0006859","EFO_0003931","EFO_0002506","HP_0030839","HP_0001385","HP_0030838","MONDO_0007254","HP_0001822","EFO_0003843","HP_0000023","EFO_0008553"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for pain and has 4 investigational indications."}
{"id":"CHEMBL190279","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C","inchiKey":"DUHUCHOQIDJXAT-OLVMNOGESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALFAXALONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alfaxalone","Alphaxalone","GR 2/234"],"crossReferences":{"PubChem":["144204435","170466428","50104098","50104100","56422127","855840","90341788"],"Wikipedia":["Alfaxalone"],"drugbank":["DB11371"],"chEBI":["34531"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL194126","canonicalSmiles":"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O","inchiKey":"VEGXETMJINRLTH-BOZYPMBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL194126","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04729"],"chEBI":["27784"]},"childChemblIds":["CHEMBL1087542"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1950554","canonicalSmiles":"Nc1nc(N/N=C/C2CCCCC2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"XJFMHMFFBSOEPR-DNZQAUTHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BINODENOSON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Corvue"],"synonyms":["Binodenoson","MRE-0470","MRE0470","Wrc0470"],"crossReferences":{"drugbank":["DB04853"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2008544","canonicalSmiles":"CCc1ccc2c(c1)N(CC(C)CN(C)C)c1ccccc1S2","inchiKey":"USKHCLAXJXCWMO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETYMEMAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etymemazine"],"crossReferences":{"drugbank":["DB11517"]},"childChemblIds":["CHEMBL1967567"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2028294","canonicalSmiles":"O=[Se]([O-])O.[Na+]","inchiKey":"OHYAUPVXSYITQV-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2028294","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2009089","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["575825"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2051965","canonicalSmiles":"[2H]C([2H])([2H])C1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1([2H])[2H]","inchiKey":"SHGAZHPCJJPHSC-GOWYKSNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2051965","maximumClinicalTrialPhase":0,"parentId":"CHEMBL38","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096635","canonicalSmiles":"N[14C](N)=O","inchiKey":"XSQUKJJJFZCRTK-NJFSPNSNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UREA C 14","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL985","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pytest","Pytest kit"],"synonyms":["Urea (14C)","Urea c 14","Urea, c-14"],"crossReferences":{"DailyMed":["urea,%20c-14"],"drugbank":["DB09513"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997."}
{"id":"CHEMBL2104282","canonicalSmiles":"CCN(CC)CCn1c(-c2ccccc2)noc1=N","inchiKey":"MGSPDRWOUCPKNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMOLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imolamine"],"crossReferences":{"drugbank":["DB09284"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105053","canonicalSmiles":"CCC(=O)C1(c2ccccc2)CCN(CCOCCO)CC1","inchiKey":"FVYYUBRKVVOOAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROXYPROPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Droxypropine"],"crossReferences":{"drugbank":["DB13436"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105212","canonicalSmiles":"CCC(C)C(C)C1Nc2cc(Cl)c(S(N)(=O)=O)cc2S(=O)(=O)N1","inchiKey":"KJLLKLRVCJAFRY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEBUTIZIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mebutizide"],"crossReferences":{"drugbank":["DB13430"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105534","canonicalSmiles":"CS(=O)(=O)c1ccc(-c2cn3ccccc3n2)cc1","inchiKey":"VSLIUWLPFRVCDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOLIMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zolimidine","Zoliridine"],"crossReferences":{"PubChem":["170466528"],"drugbank":["DB13593"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105612","canonicalSmiles":"CCC(Oc1ccccc1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12","inchiKey":"HOCWPKXKMNXINF-XQERAMJGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPICILLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baycillin"],"synonyms":["Phenoxypropylpenicillin","Propicillin","Propicillin potassium"],"crossReferences":{"PubChem":["144205529"],"drugbank":["DB13660"],"chEBI":["52429"]},"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL2105697","canonicalSmiles":"COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1.Cl","inchiKey":"VYUWDIKZJLOZJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERUBULIN HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL492399","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Azixa"],"synonyms":["MPC-6827","Verubulin hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105705","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@]3(C)C([C@H](C)C/C=C/S(=O)(=O)C(C)(C)C)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O","inchiKey":"RFQHCLMGLJGZNV-UXXOMSPDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUNACALCIPOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CTA-018","CTA018","Lunacalcipol"],"count":4,"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_1001173","EFO_0003884","EFO_0000676","EFO_0009909"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2106186","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)NC(c1ccccc1)NC2=O","inchiKey":"DBDTUXMDTSTPQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENQUIZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Idrolone"],"synonyms":["Fenquizone","M.G. 13054"],"crossReferences":{"drugbank":["DB13708"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106317","canonicalSmiles":"Nc1c(I)cc(I)c(C(=O)N(CCC(=O)O)c2ccccc2)c1I","inchiKey":"FJYJNLIEGUTPIJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOBENZAMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Osbil"],"synonyms":["Iobenzamic acid"],"crossReferences":{"PubChem":["170465948"],"drugbank":["DB13428"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106650","canonicalSmiles":"O=C1NC2CCCCN2C12CCN(CCCN1c3ccccc3CCc3ccc(Cl)cc31)CC2","inchiKey":"PXUIZULXJVRBPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOSAPRAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mosapramine","Mosapramine hydrochloride"],"crossReferences":{"PubChem":["144206880"],"drugbank":["DB13676"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106968","canonicalSmiles":"Cc1ccc2c(c1)Sc1ccc(C)cc1S2","inchiKey":"AHXDSVSZEZHDLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MESULFEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mesulfen","Mesulphen","Thianthol"],"crossReferences":{"drugbank":["DB13356"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108030","drugType":"Antibody","blackBoxWarning":false,"name":"EXBIVIRUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hepex-b"],"synonyms":["Exbivirumab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108327","drugType":"Protein","blackBoxWarning":false,"name":"LANCOVUTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lancovutide","MOLI-1901","MOLI1901","Moli1901"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108674","drugType":"Protein","blackBoxWarning":false,"name":"RAMATERCEPT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ace-031"],"synonyms":["ACE-031","Ramatercept"],"count":2,"linkedTargets":{"rows":["ENSG00000138379"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896","EFO_0002970"],"count":2},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108952","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"DEXTRAN SULFATE SODIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dextran sulfate sodium"],"count":1,"description":"Oligosaccharide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109138","drugType":"Antibody","blackBoxWarning":false,"name":"MOROLIMUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Morolimumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109314","drugType":"Antibody","blackBoxWarning":false,"name":"GS-CDA1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-CDA1","Gs-cda1"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109391","drugType":"Antibody","blackBoxWarning":false,"name":"MDX-447","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD-82633","MDX-447","Mdx-447"],"count":1,"linkedTargets":{"rows":["ENSG00000146648","ENSG00000150337"],"count":2},"linkedDiseases":{"rows":["EFO_1000158"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109446","drugType":"Antibody","blackBoxWarning":false,"name":"KD-247","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KD-247","Kd-247"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109530","drugType":"Antibody","blackBoxWarning":false,"name":"ASK-8007","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASK-8007","Ask-8007"],"count":1,"linkedTargets":{"rows":["ENSG00000118785"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109559","drugType":"Antibody","blackBoxWarning":false,"name":"J591 177LU","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["177 LU-J591","HUJ591-GS","J591 177lu"],"count":1,"linkedTargets":{"rows":["ENSG00000086205"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL21156","canonicalSmiles":"CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1","inchiKey":"VNDWQCSOSCCWIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL21156","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103905610","174006716"],"drugbank":["DB04716"],"chEBI":["87103"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146142","canonicalSmiles":"N=C1NCC[C@H]([C@@H]2NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)C[C@@H](N)[C@H](O)CCN)CNC2=O)N1","inchiKey":"HPWIIERXAFODPP-GHBBWTPBSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ENVIOMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enviomycin","Enviomycin sulfate"],"crossReferences":{"drugbank":["DB08993"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL217092","canonicalSmiles":"CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1","inchiKey":"OUKYUETWWIPKQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARACATINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZ-10353926","AZD-0530","AZD0530","Azd-0530","Saracatinib"],"crossReferences":{"PubChem":["137275842","164339484"],"drugbank":["DB11805"]},"childChemblIds":["CHEMBL2105677"],"count":19,"linkedTargets":{"rows":["ENSG00000097007","ENSG00000197122"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0000637","EFO_0000365","EFO_0004329","MONDO_0015686","EFO_0000756","EFO_0000249","MONDO_0008170","EFO_1000657","MONDO_0021063","Orphanet_538","MONDO_0008315","EFO_0003060","EFO_0003829","EFO_0000311","MONDO_0002158","EFO_1000044","EFO_1000581","EFO_0006861","Orphanet_337"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 19 investigational indications."}
{"id":"CHEMBL217894","canonicalSmiles":"CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(OC)C1=O","inchiKey":"VMEGFMNVSYVVOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECYLUBIQUINONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Decylubiquinone"],"crossReferences":{"PubChem":["26756779","26756780"],"drugbank":["DB07640"],"chEBI":["52020"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2179529","canonicalSmiles":"O=C(c1ccc(Cl)o1)N1CC2CNCC2C1","inchiKey":"GTUIQNHJSXQMKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD1446","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-1446","AZD1446 HCL","Azd 1446","Azd1446","TC-6683","TC6683","TC6683 HCL"],"count":2,"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["EFO_0003888","EFO_0000249"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL220050","canonicalSmiles":"C[C@@H](C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)/C=C/c2ccc(Cl)s2)C1=O","inchiKey":"ACEFOQMQINFMRW-DYCFVMESSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW813893","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW813893","Gw813893"],"crossReferences":{"drugbank":["DB07278"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL220360","canonicalSmiles":"C[C@H](NC(=O)C(C)(C)Oc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1","inchiKey":"QLYKJCMUNUWAGO-GAJHUEQPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARANABANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0364","MK-0634","Mk0364","Taranabant"],"crossReferences":{"drugbank":["DB06624"]},"count":4,"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["HP_0000020","EFO_0003768","EFO_0001360","EFO_0001073"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL226403","canonicalSmiles":"O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21","inchiKey":"OWFLADWRSCINST-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL226403","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103905260"],"drugbank":["DB08358"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL227744","canonicalSmiles":"N=C(NCCC[C@H](N)C(=O)O)N[N+](=O)[O-]","inchiKey":"MRAUNPAHJZDYCK-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N (g)-NITRO-L-ARGININE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-N-Nitroarginine","L-Nitroarginine","L-Nw-Nitroarginine"],"crossReferences":{"PubChem":["11113630","50104528","50104529","50104530","90341713"],"drugbank":["DB04223"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2325429","canonicalSmiles":"Cc1ccc(C(=O)N(CCCN)[C@@H](c2oc3cc(Cl)ccc3c(=O)c2Cc2ccccc2)C(C)C)cc1","inchiKey":"PGXYIBJJCLWJST-MUUNZHRXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-743921","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-743921","SB-743921 FREE BASE","Sb 743921","Sb-743921"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2356648","canonicalSmiles":"Cl.Cl.Cl.N=C(N)NCCCCCCC(=O)NC(O)C(=O)NCCCCNCCCN","inchiKey":"AXSPHUWXYSZPBG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUSPERIMUS TRIHYDROCHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL406117","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["15-deoxyspergualin trihydrochloride","BMS-181173","BMY-42215-1","Gusperimus hydrochloride","Gusperimus trihydrochloride","NKT-01","NSC-356894"],"crossReferences":{"PubChem":["144206777"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2362693","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1.Cl.Cl","inchiKey":"JINNGBXKBDUGQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2362693","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1085699","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206047","170465961"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL239507","canonicalSmiles":"CNCc1cc(=O)oc2cc(OCc3cccc(Cl)c3)ccc12","inchiKey":"JMGUSOLCNQVZCT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL239507","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07513"]},"childChemblIds":["CHEMBL593763"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2443262","canonicalSmiles":"COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1","inchiKey":"DMNOVGJWPASQDL-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OLICERIDINE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Olynvik"],"synonyms":["Oliceridine","TRV-130","TRV130"],"crossReferences":{"drugbank":["DB14881"]},"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for pain. This drug has a black box warning from the FDA."}
{"id":"CHEMBL253371","canonicalSmiles":"CCN(CCCc1ccccc1)CCCc1ccccc1","inchiKey":"ZPFXAOWNKLFJDN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALVERINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Alverine"],"crossReferences":{"PubChem":["50103849","50104229","50104230"],"Wikipedia":["Alverine"],"drugbank":["DB01616"],"chEBI":["518413"]},"childChemblIds":["CHEMBL1408594"],"count":1,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000101076"],"count":2},"linkedDiseases":{"rows":["EFO_0010282","EFO_0000555"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL254219","canonicalSmiles":"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O","inchiKey":"WDJUZGPOPHTGOT-XUDUSOBPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIGITOXIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crystodigin","Digimerck","Nativelle digitaline"],"synonyms":["CRYSTODIGIN","Digitoxin","Digitoxoside","NSC-7529"],"crossReferences":{"PubChem":["11533060","144205212","144212586","170464713","26754428","26754429"],"Wikipedia":["Digitoxin"],"drugbank":["DB01396"],"chEBI":["28544"]},"count":2,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000163399","ENSG00000018625","ENSG00000105409","ENSG00000132681"],"count":4},"linkedDiseases":{"rows":["Orphanet_586","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL254468","canonicalSmiles":"N[C@]1(C(=O)O)C[C@@H]([18F])C1","inchiKey":"NTEDWGYJNHZKQW-DGMDOPGDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL254468","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1908917","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13146"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL260585","canonicalSmiles":"Oc1cc(Cc2ccccn2)ccc1Oc1ccc(Cl)cc1Cl","inchiKey":"AOVDSWPGWPRTSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL260585","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07287"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL26717","canonicalSmiles":"NS(=O)(=O)c1ccc2c(c1)CNCC2","inchiKey":"UGLLZXSYRBMNOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SK&F-29661","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SK&F-29661","SK-29661"],"crossReferences":{"drugbank":["DB03468"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282093","canonicalSmiles":"NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(Cl)cc2)cc1","inchiKey":"NSQNZEUFHPTJME-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SC-58236","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SC-58236"],"crossReferences":{"drugbank":["DB14059"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL29609","canonicalSmiles":"Cc1cc(CCCOc2c(C)cc(-c3noc(C(F)(F)F)n3)cc2C)on1","inchiKey":"KQOXLKOJHVFTRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PLECONARIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pleconaril","VP 63843","VP-63843","WIN 63843","WIN-63843"],"crossReferences":{"PubChem":["170466405"],"Wikipedia":["Pleconaril"],"drugbank":["DB05105"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL298826","canonicalSmiles":"Clc1ccc([C@H]2C[C@@H]3CC[C@H]2N3)cn1","inchiKey":"NLPRAJRHRHZCQQ-IVZWLZJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(-)-EPIBATIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-Epibatidine"],"crossReferences":{"Wikipedia":["Epibatidine"],"drugbank":["DB07720"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL298827","canonicalSmiles":"O=C(O)CNC(=O)[C@@H](CS)Cc1ccccc1","inchiKey":"LJJKNPQAGWVLDQ-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-THIORPHAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111898","11112848"],"drugbank":["DB08626"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL301327","canonicalSmiles":"COc1ccc2c(c1)OC(C)(C)[C@@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1","inchiKey":"XZEUAXYWNKYKPL-WDYNHAJCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVORMELOXIFENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Levormeloxifene"],"crossReferences":{"PubChem":["144206269"],"Wikipedia":["Levormeloxifene","Ormeloxifene"],"drugbank":["DB13310"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039558","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIRINOTECAN PEGOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etirinotecan pegol","NKTR-102"],"count":9,"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0008170","MONDO_0007254","EFO_0002499","EFO_0002501","EFO_0000519","EFO_0003060","EFO_1001951","EFO_0000311"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3039566","drugType":"Unknown","blackBoxWarning":false,"name":"SUCROFERRIC OXYHYDROXIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Velphoro"],"synonyms":["PA21","Sucroferric oxyhydroxide"],"crossReferences":{"DailyMed":["sucroferric%20oxyhydroxide"],"DrugCentral":["5121"]},"count":1,"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 2013 and has 1 investigational indication."}
{"id":"CHEMBL30816","canonicalSmiles":"CC(C)NCC(O)c1ccc(Cl)c(Cl)c1","inchiKey":"VKMGSWIFEHZQRS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICHLOROISOPROTERENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Dichloroisoprenaline"],"drugbank":["DB12803"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3133301","canonicalSmiles":"[3H]C([3H])([3H])Oc1ccc(C(CN(C([3H])([3H])[3H])C([3H])([3H])[3H])C2(O)CCCCC2)cc1","inchiKey":"PNVNVHUZROJLTJ-HCMTUZIUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3133301","maximumClinicalTrialPhase":0,"parentId":"CHEMBL637","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL31344","canonicalSmiles":"O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12","inchiKey":"KNBSYZNKEAWABY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL31344","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04175"]},"childChemblIds":["CHEMBL169776","CHEMBL3264006"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3182097","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.c1ccc(CNCCNCc2ccccc2)cc1","inchiKey":"BVGLIYRKPOITBQ-ANPZCEIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3182097","maximumClinicalTrialPhase":0,"parentId":"CHEMBL29","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205140","170465096"],"chEBI":["51352"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3182621","canonicalSmiles":"Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O","inchiKey":"RWEVIPRMPFNTLO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-8330","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARRY-424704","ARRY-704","AZD-8330","Azd 8330","Azd-8330"],"crossReferences":{"PubChem":["174006482"],"drugbank":["DB06061"]},"count":1,"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL31891","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1Br","inchiKey":"BFCRRLMMHNLSCP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRODIMOPRIM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brodimoprim"],"crossReferences":{"Wikipedia":["Brodimoprim"],"drugbank":["DB13795"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3260505","canonicalSmiles":"CCc1cnc(N2CCC(c3nc(COc4ccc(-n5cnnn5)cc4)cs3)CC2)nc1","inchiKey":"NFTMKHWBOINJGM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MBX-2982","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mbx-2982"],"crossReferences":{"drugbank":["DB12345"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL329123","canonicalSmiles":"CCCc1c(OCCCOc2cc(O)c(-c3ccc(F)cc3)cc2CC)cccc1Oc1ccccc1C(=O)O","inchiKey":"YFIZRWPXUYFCSN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETALOCIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etalocib","LY-193111","LY-293111","LY293111","Ly-293111","Ly293111","VML 295"],"crossReferences":{"Wikipedia":["Etalocib"],"drugbank":["DB12850"]},"count":3,"linkedTargets":{"rows":["ENSG00000132170","ENSG00000213903"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3301578","drugType":"Antibody","blackBoxWarning":false,"name":"EMIBETUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C-8H241","Emibetuzumab","LA480","LY-2875358","LY2875358"],"count":3,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["MONDO_0001056","EFO_0003060","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3330707","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](NC(=N)N)C=C(C(=O)[O-])O[C@H]1[C@H](O)[C@H](O)CO.[Na+]","inchiKey":"MOHYGJPDTFGLMY-VCFRRRQNSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3330707","maximumClinicalTrialPhase":0,"parentId":"CHEMBL222813","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL333325","canonicalSmiles":"C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@@](Cn1cncn1)(OCOP(=O)(O)O)c1ccc(F)cc1F","inchiKey":"SYTNEMZCCLUTNX-NPMXOYFQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSRAVUCONAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-379224","E-1224 FREE ACID","E1224 FREE ACID","Fosravuconazole"],"crossReferences":{"drugbank":["DB15204"],"chEBI":["34549"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL333410","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(CC(O)c2ccccc2)CC1C","inchiKey":"FRPRNNRJTCONEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL333410","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01570"]},"childChemblIds":["CHEMBL544820"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3348861","canonicalSmiles":"O=C1c2c(O)cc(O)cc2O[C@H](c2cc(O)c(O)c(O)c2)[C@H]1O","inchiKey":"KJXSIXMJHKAJOD-LSDHHAIUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPELOPSIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ampelopsin"],"crossReferences":{"drugbank":["DB15645"],"chEBI":["28429"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3526802","canonicalSmiles":"O=C(CBr)N1CC([N+](=O)[O-])([N+](=O)[O-])C1","inchiKey":"JODKFOVZURLVTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RRX-001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rrx 001","Rrx-001"],"crossReferences":{"drugbank":["DB12060"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3544943","canonicalSmiles":"Cl.O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12","inchiKey":"UNDKJUKLBNARIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-863233","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3544944","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-863233","XL-413"],"linkedTargets":{"rows":["ENSG00000097046"],"count":1},"linkedDiseases":{"rows":["MONDO_0004111","MONDO_0024880"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545181","canonicalSmiles":"C[N+]1(C)[C@H]2C[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@@H]1[C@H]1O[C@@H]21.O.[Br-]","inchiKey":"MQLXPRBEAHBZTK-SEINRUQRSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOTROPIUM BROMIDE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1900528","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Spiriva","Spiriva respimat"],"synonyms":["BA 679 BR","BA-679 BR","BA-679-BR","BA-679BR","Tiotropium bromide","Tiotropium bromide hydrate","Tiotropium bromide monohydrate"],"crossReferences":{"DailyMed":["tiotropium%20bromide"]},"count":8,"approvedIndications":["HP_0006536","EFO_0000270","EFO_0000464","EFO_0006505","EFO_0000341"],"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["HP_0000083","HP_0006536","EFO_0000270","EFO_0000464","EFO_0006505","EFO_1001919","Orphanet_586","EFO_0000341","MONDO_0004784"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 5 approved and 3 investigational indications."}
{"id":"CHEMBL3545247","drugType":"Small molecule","blackBoxWarning":false,"name":"CAL-263","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cal-263"],"count":1,"linkedTargets":{"rows":["ENSG00000171608","ENSG00000105851"],"count":2},"linkedDiseases":{"rows":["EFO_0005854"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545291","canonicalSmiles":"CN(C)C(=O)CCn1nc(Nc2ccc3c(c2)OC(F)(F)O3)nc1-c1ccncc1","inchiKey":"IURMHZBQEYNQOH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-39393406","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj-39393406"],"crossReferences":{"drugbank":["DB11867"]},"count":3,"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["EFO_0004319","MONDO_0002050","EFO_0000692"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545327","drugType":"Small molecule","blackBoxWarning":false,"name":"TTP-607","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ttp-607"],"count":1,"linkedTargets":{"rows":["ENSG00000087586","ENSG00000178999","ENSG00000105146"],"count":3},"linkedDiseases":{"rows":["EFO_0000574"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545384","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-85635","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sb-85635"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545416","drugType":"Small molecule","blackBoxWarning":false,"name":"HENATINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Henatinib"],"count":1,"linkedTargets":{"rows":["ENSG00000128052"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3559672","drugType":"Small molecule","blackBoxWarning":false,"name":"RAUWOLFIA SERPENTINA","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hiwolfia","Hyserpin","Koglucoid","Raudixin","Rauserpin","Rauval","Rauwolfia serpentina","Wolfina"],"synonyms":["Rauvolfia serpentina root","Rauwolfia alkaloids","Rauwolfia alkaloids, whole root","Rauwolfia serpentina","Rauwolfia serpentina alseroxylon","Rauwolfia serpentina root"],"count":2,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for hypertension and has 1 investigational indication."}
{"id":"CHEMBL361054","canonicalSmiles":"O=c1[nH]c(=O)n(CCCCN2CC=C(c3ccccc3)CC2)c2cccc(F)c12","inchiKey":"PNPFDRCIGCUCMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL361054","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07787"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707397","drugType":"Small molecule","blackBoxWarning":false,"name":"MR-1817","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mr-1817"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3785909","canonicalSmiles":"COCCOc1cnc2ccn([C@H](C)c3nnc4c(F)cc(-c5cnn(C)c5)cn34)c(=O)c2c1","inchiKey":"DWHXUGDWKAIASB-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3785909","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15639"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL382301","canonicalSmiles":"CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1","inchiKey":"VWXRQYYUEIYXCZ-OBIMUBPZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ATOSIBAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tractocile"],"synonyms":["Atosiban","CAP-449","CAP-476","CAP-581","F-314","ORF 22164","ORF-22164","RW-22164","RWJ 22164","RWJ-22164"],"crossReferences":{"PubChem":["144207023","29217473"],"drugbank":["DB09059"]},"count":1,"linkedTargets":{"rows":["ENSG00000180914"],"count":1},"linkedDiseases":{"rows":["EFO_0003917"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL391737","canonicalSmiles":"C[C@@H](C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)CCc2ccc(Cl)s2)C1=O","inchiKey":"IAUZEBLXCOCAFL-JSGCOSHPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL391737","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07277"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3947131","canonicalSmiles":"[2H]C1([2H])CN(C(=O)c2ccnc(C(F)(F)F)c2F)CC([2H])([2H])C1([2H])N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1","inchiKey":"KTBSXLIQKWEBRB-CXRAHBMQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3947131","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3622820","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989547","canonicalSmiles":"Cc1ccc(Oc2ccccc2-c2csc(N=C3NCCCN3)n2)c(C)c1","inchiKey":"TYBHXIFFPVFXQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABAFUNGIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abafungin","BAY W 6341 "],"crossReferences":{"drugbank":["DB06395"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989603","canonicalSmiles":"CCCCCCCCCCCCSCC(COP(=O)(O)OC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)C[C@@H]1N=[N+]=[N-])OCCCCCCCCCC","inchiKey":"IBHARWXWOCPXCR-WELGVCPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOZIVUDINE TIDOXIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fozivudine tidoxil"],"crossReferences":{"drugbank":["DB12423"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989912","canonicalSmiles":"Cl.O=C1CC[C@H](N2Cc3c(OCc4ccc(CN5CCOCC5)cc4)cccc3C2=O)C(=O)N1","inchiKey":"VVHQVXXPZDALDV-BOXHHOBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBERDOMIDE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3989927","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-220","Iberdomide hydrochloride"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3989922","canonicalSmiles":"Cc1ccc(S(=O)(=O)O)cc1.NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12.O","inchiKey":"ACNPUCQQZDAPJH-FMOMHUKBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIRAPARIB TOSYLATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1094636","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zejula"],"synonyms":["MK-4827-TOSYLATE","Niraparib tosylate","Niraparib tosylate monohydrate"],"crossReferences":{"DailyMed":["niraparib%20tosylate"]},"count":3,"approvedIndications":["EFO_0001075","EFO_1001100","EFO_1000251"],"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484"],"count":2},"linkedDiseases":{"rows":["EFO_0009780","EFO_0001075","EFO_1001100","EFO_1000251"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved indications."}
{"id":"CHEMBL3989941","canonicalSmiles":"Cn1c(CCCCCCC(=O)NO)nc2cc(N(CCCl)CCCl)ccc21","inchiKey":"GISXTRIGVCKQBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TINOSTAMUSTINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EDO-S 101","EDO-S-101","EDO-S101","Tinostamustine"],"crossReferences":{"drugbank":["DB15147"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL400431","canonicalSmiles":"CCc1nc(N)nc(N)c1-c1ccc2c(c1)N(CCCOC)C(=O)C(C)(C)O2","inchiKey":"WPAPODFGOZXFLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL400431","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07174"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL405110","canonicalSmiles":"CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1.[Cl-]","inchiKey":"CXKWCBBOMKCUKX-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLTHIONINIUM CHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL191083","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206050","144212404","170465461","24811249"],"Wikipedia":["Methylene_blue","Rember"],"drugbank":["DB09241"],"chEBI":["6872"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4084907","canonicalSmiles":"Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)cn1","inchiKey":"ADGGYDAFIHSYFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIMIRALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bimiralisib","NC-B5","NCB5","PI3K-IN-2","PQR-309","PQR309","Pqr309"],"crossReferences":{"drugbank":["DB14846"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4094440","canonicalSmiles":"NS(=O)(=O)c1cncc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)c1","inchiKey":"XGKULQQVQWCASY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-919373","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-919373"],"crossReferences":{"drugbank":["DB15047"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL410968","canonicalSmiles":"C=C(NC(=O)C(=C)NC(=O)c1csc(C2=NC3c4csc(n4)C4NC(=O)c5csc(n5)C(C(C)(O)C(C)O)NC(=O)C5CSC(=N5)/C(=C\\C)NC(=O)C(C(C)O)NC(=O)c5csc(n5)C3(CC2)NC(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC(=O)C(C(C)CC)NC2C=Cc3c(C(C)O)cc(nc3C2O)C(=O)OC4C)n1)C(N)=O","inchiKey":"NSFFHOGKXHRQEW-DVRIZHICSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"CHEMBL410968","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204055","26750027"],"drugbank":["DB11467"]},"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL415","canonicalSmiles":"CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21","inchiKey":"GDLIGKIOYRNHDA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLOMIPRAMINE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Anafranil","Clomipramine","NSC-169865"],"crossReferences":{"DailyMed":["clomipramine%20hydrochloride"],"PubChem":["104171137","11110978","11110979","11113368","124879726","144203668","170464702","26751616","50100206","50104278","90340575"],"TG-GATEs":["121"],"Wikipedia":["Clomipramine"],"drugbank":["DB01242"],"chEBI":["47780"]},"childChemblIds":["CHEMBL1200710"],"count":5,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","HP_0000726","EFO_0003761","EFO_0004242","EFO_0005230","EFO_0000692"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and is indicated for unipolar depression and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL416230","canonicalSmiles":"CCCCCCCCCCOc1cc2c(O)c(C(=O)OCC)cnc2cc1OCC","inchiKey":"JHAYEQICABJSTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECOQUINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Decoquinate","HC 1528","M&B 15497"],"crossReferences":{"PubChem":["144206276","170466244","50125820"],"Wikipedia":["Decoquinate"],"drugbank":["DB11394"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL417675","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)NCCO","inchiKey":"HXYVTAGFYLMHSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALMIDROL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AM 3112","NSC-23320","Palmidrol"],"crossReferences":{"PubChem":["11113754","144203773","170466102","26751936","50104611","56463464","85231178","90341052"],"Wikipedia":["Palmitoylethanolamide"],"drugbank":["DB14043"],"chEBI":["71464"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL419499","canonicalSmiles":"O=C(NCC(=O)N1[C@H](C(=O)O)CC[C@@H]1c1ccccc1)[C@@H](S)Cc1ccccc1","inchiKey":"ZWDQTNWLXALTOV-QYZOEREBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL419499","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02669"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL420910","canonicalSmiles":"CN(CCCC1CCCCC1)C(=O)[C@H](CCC(=O)O)NC(=O)N(CC(=O)O)Cc1ccc(OP(=O)(O)O)cc1","inchiKey":"JSBQUMXQEBZYPW-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL420910","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01773"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4227736","canonicalSmiles":"Cc1ccc(C(=O)Oc2ccc(C(CN(C)C)C3(O)CCCCC3)cc2)cc1","inchiKey":"QKYBZJLEMOZFFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANSOFAXINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ansofaxine","LPM-570065","LPM570065","LY-03005","LY03005","Ly03005","ODVP2","Toludesvenlafaxine"],"crossReferences":{"drugbank":["DB15052"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL426926","canonicalSmiles":"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O","inchiKey":"MKKYBZZTJQGVCD-XTCKQBCOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARBEKACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arbekacin","Arbekacin sulfate"],"crossReferences":{"PubChem":["50112783"],"drugbank":["DB06696"],"chEBI":["37922"]},"childChemblIds":["CHEMBL3184482"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL429023","canonicalSmiles":"C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1","inchiKey":"JUVIOZPCNVVQFO-HBGVWJBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROTENONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["104171353","11113277","124883112","144204370","144209102","144211012","170466816","26753651","26753652","50107017","50107018","50107019","85231344","87142","90340839"],"Wikipedia":["Rotenone"],"drugbank":["DB11457"],"chEBI":["28201"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297166","drugType":"Unknown","blackBoxWarning":false,"name":"TEICOPLANIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Targocid"],"synonyms":["MDL 507","MDL-507","Teicoplanin"],"count":5,"approvedIndications":["EFO_0000771"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 4 investigational indications."}
{"id":"CHEMBL4297203","canonicalSmiles":"O=C(CN[C@@H]1CCNC1)N1CCC[C@H]1B(O)O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"SVWHNLVZPGXBNS-RJUBDTSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DUTOGLIPTIN TARTRATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4296719","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dutogliptin tartrate","PHX-1149","PHX1149T","Phx1149t"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297273","canonicalSmiles":"Cl.N[C@H]1C[C@@H](C(=O)O)CC1=C(F)F","inchiKey":"PGVAKHBXGXBOSB-WINKWTMZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CPP-115","maximumClinicalTrialPhase":1,"parentId":"CHEMBL146927","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cpp-115"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297332","canonicalSmiles":"CCOCCCCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1C.O=C(O)[C@H](O)[C@@H](O)C(=O)O","inchiKey":"DZRQMHSNVNTFAQ-IVGJVWKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UT-231B","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4300049","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ut-231b"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297343","canonicalSmiles":"CCCCCC=CCC=CCCCCCCC(O)C(=O)O","inchiKey":"AFDSETGKYZMEEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABTL-0812","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABTL0812","Abtl-0812","Abtl0812"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297397","canonicalSmiles":"O=c1c(O)c(-c2ccc(O)c(OP(=O)(O)O)c2)oc2cc(O)cc(O)c12","inchiKey":"UWJBYNLLMAPJMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUERCETIN-3'-O-PHOSPHATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LIM-0705","Lim-0705","Quercetin-3'-o-phosphate"],"crossReferences":{"drugbank":["DB12937"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297548","drugType":"Unknown","blackBoxWarning":false,"name":"FIMASARTAN POTASSIUM TRIHYDRATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BR-A-657","Br-a-657","Fimasartan potassium trihydrate"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297589","canonicalSmiles":"CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1","inchiKey":"FYXHWMQPCJOJCH-GMAHTHKFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELATOGREL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-246475","Act-246475","Selatogrel"],"crossReferences":{"drugbank":["DB15163"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4297637","canonicalSmiles":"CC(=O)OC/C=C(C)/C=C/C=C(C)\\C=C\\C1=C(C)CCCC1(C)C","inchiKey":"QGNJRVVDBSJHIZ-AQDFTDIISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZURETINOL ACETATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["QLT-091001","QLT091001","Qlt091001","Zuretinol acetate"],"crossReferences":{"drugbank":["DB12112"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297871","drugType":"Antibody","blackBoxWarning":false,"name":"CAMIDANLUMAB TESIRINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADCT-301","ADCT-301 TESIRINE","ADCT301","Adct 301","Adct 502","Adct-301 tesirine","Camidanlumab tesirine"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297952","drugType":"Unknown","blackBoxWarning":false,"name":"FB-825","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FB-825","FB825","Fb-825","Fb825"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297975","drugType":"Unknown","blackBoxWarning":false,"name":"RECOMBINANT VARICELLA ZOSTER VIRUS (VZV) GLYCOPROTEIN E","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Herpes zoster vaccine gsk1437173a","Recombinant varicella zoster virus (vzv) glycoprotein e","Shingrix"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298145","canonicalSmiles":"CC#CC[C@H](C)[C@H](O)/C=C/[C@@H]1[C@H]2c3cccc(CCCC(=O)[O-])c3O[C@H]2C[C@H]1O.[K+]","inchiKey":"RSTLTBUTQXBUMK-ZTWNIFTGSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ESUBERAPROST POTASSIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3137314","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Esuberaprost potassium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL43452","canonicalSmiles":"Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O","inchiKey":"UVSMNLNDYGZFPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"POMALIDOMIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imnovid","Pomalyst"],"synonyms":["CC-4047","IMID 3","IMID-3","Pomalidomide"],"crossReferences":{"DailyMed":["pomalidomide"],"PubChem":["174007398"],"Wikipedia":["Pomalidomide"],"drugbank":["DB08910"],"chEBI":["72690"]},"count":28,"approvedIndications":["EFO_0001378","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000139842","ENSG00000113851","ENSG00000167986","ENSG00000100387"],"count":4},"linkedDiseases":{"rows":["MONDO_0044903","EFO_0000558","Orphanet_232","EFO_0005952","EFO_0000540","Orphanet_85443","EFO_0002430","EFO_0004251","EFO_0004244","EFO_0000183","EFO_0000717","EFO_0009441","EFO_0000616","MONDO_0013730","EFO_0002618","EFO_0000403","EFO_0002939","EFO_1001968","EFO_0002429","MONDO_0008315","EFO_0009448","EFO_0006738","EFO_0006475","Orphanet_774","EFO_0000702","EFO_0001378","MONDO_0015564","MONDO_0024880","Orphanet_314701"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for multiple myeloma and immune system disease and has 26 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL445699","canonicalSmiles":"CCC[C@@]1(CCc2ccccc2)CC(O)=C([14C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1","inchiKey":"SUJUHGSWHZTSEU-MWQIXQBFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL445699","maximumClinicalTrialPhase":0,"parentId":"CHEMBL222559","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15108"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL450449","canonicalSmiles":"COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H](O)[C@@H]3Cc5cc(C)c(OC)c(O)c5[C@H]([C@H]21)N3C)OCO4","inchiKey":"PKVRCIRHQMSYJX-AIFWHQITSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRABECTEDIN","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Yondelis"],"synonyms":["ET-743","Ecteinascidins trabectedin","NSC-648766","Trabectedin","Yondelis"],"crossReferences":{"DailyMed":["trabectedin"],"PubChem":["144206315","144206787"],"drugbank":["DB05109"],"chEBI":["84050"]},"count":24,"approvedIndications":["EFO_0000616","EFO_0000564","EFO_0000569","EFO_0000311"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 4 approved and 20 investigational indications."}
{"id":"CHEMBL4591096","canonicalSmiles":"Cl.O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F","inchiKey":"FPTQDMHWQWTIAX-UHFFFAOYSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4591096","maximumClinicalTrialPhase":0,"parentId":"CHEMBL652","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594331","drugType":"Protein","blackBoxWarning":false,"name":"DAZODALIBEP","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dazodalibep","MEDI-4920","MEDI4920","Medi 4920","VIB-4920","VIB4920","Vib4920"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594475","drugType":"Protein","blackBoxWarning":false,"name":"GLUCAGON-LIKE PEPTIDE 1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glp-1","Glucagon-like peptide 1"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594504","drugType":"Unknown","blackBoxWarning":false,"name":"TCN-202","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TCN-202","TCN202","Tcn-202"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL471243","canonicalSmiles":"Cl.NC(=O)c1ccc2c(c1O)[C@]13CCN(CC4CC4)[C@H](C2)[C@]1(O)CCC(=O)C3","inchiKey":"LRMKVAABEFFIDK-GPCMIKKWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CCDC 710249","maximumClinicalTrialPhase":0,"parentId":"CHEMBL426084","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCDC 710249"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL47590","canonicalSmiles":"CNc1nc(C)c(-c2ccnc(Nc3ccc(O)cc3)n2)s1","inchiKey":"OTMLAWRVLMYMDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL47590","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04407"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL480558","canonicalSmiles":"CCC(CC)[C@@H](CO)NS(=O)(=O)c1ccc(Cl)s1","inchiKey":"PYZFRRVBPNGCBX-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSI-136","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsi-136"],"crossReferences":{"drugbank":["DB12819"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL482811","canonicalSmiles":"CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@@H]1CCCC[C@H]1N1CCCC1.CS(=O)(=O)O","inchiKey":"OJPHNZCUXUUVKU-JAXOOIEVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"U-50488 METHANE SULFONATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL441765","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NCG-C00093883-01","U-50488 methane sulfonate","U-50488H"],"crossReferences":{"PubChem":["11112023","11532953","56422173"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL483254","canonicalSmiles":"Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1","inchiKey":"FPOHNWQLNRZRFC-ZHACJKMWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PANOBINOSTAT","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Farydak"],"synonyms":["LBH589","Panobinostat"],"crossReferences":{"DailyMed":["panobinostat%20lactate"],"drugbank":["DB06603"],"chEBI":["85990"]},"childChemblIds":["CHEMBL3545368"],"count":49,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000108840","ENSG00000094631","ENSG00000061273","ENSG00000068024","ENSG00000163517","ENSG00000116478","ENSG00000100429","ENSG00000147099","ENSG00000171720","ENSG00000048052","ENSG00000196591"],"count":11},"linkedDiseases":{"rows":["MONDO_0009348","MONDO_0044903","EFO_0004708","Orphanet_232","EFO_1001901","EFO_0000756","EFO_0000681","EFO_0002913","MONDO_0007254","EFO_1000657","EFO_0004252","EFO_0005952","MONDO_0021063","EFO_1001469","EFO_1001951","EFO_0000565","EFO_0002430","MONDO_0001056","EFO_0000339","MONDO_0008903","EFO_0000182","EFO_0000673","EFO_0000326","EFO_0000183","EFO_0002617","EFO_0000198","EFO_0000616","MONDO_0013730","EFO_0009441","EFO_0002618","EFO_1001779","EFO_0000220","EFO_0000349","EFO_0000403","EFO_0000222","EFO_1001968","MONDO_0044881","EFO_0002429","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_0006738","EFO_1000026","MONDO_0015917","MONDO_0002691","EFO_0002892","EFO_0006475","EFO_0000764","EFO_0000574","EFO_0001378","EFO_0000519"],"count":51},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for neoplasm and cancer and has 47 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL483790","canonicalSmiles":"Nc1nc(-c2ccc(O)cc2)cs1","inchiKey":"QGSJYYIRAFRPIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL483790","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07292"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL490866","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CC[N+](CCCCCCCCN1C(=O)c3ccccc3C1=O)=C2","inchiKey":"VLGAHTYYCHWLNI-BHRZLAGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL490866","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02673"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL506981","canonicalSmiles":"COc1cccc(OC)c1-c1cc(C(=O)NC2(C(=O)O)C3CC4CC(C3)CC2C4)nn1-c1ccnc2cc(Cl)ccc12","inchiKey":"DYLJVOXRWLXDIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REMINERTANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Meclinertant","Reminertant","SR-48692","Sr48692"],"crossReferences":{"PubChem":["124950704"],"drugbank":["DB06455"]},"count":1,"linkedTargets":{"rows":["ENSG00000101188"],"count":1},"linkedDiseases":{"rows":["EFO_0000702"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL527018","canonicalSmiles":"CC#CCOc1ccc(S(=O)(=O)N[C@H](Cc2c[nH]c3ccc(C)cc23)C(=O)O)cc1","inchiKey":"SFVPXERGVLDWIS-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL527018","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07233"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL543544","canonicalSmiles":"Cl.Cl.N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1","inchiKey":"HWURPQUPKQFGJI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL543544","maximumClinicalTrialPhase":0,"parentId":"CHEMBL55","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL54714","canonicalSmiles":"O=P(O)(O)C(Nc1ccc(Cl)cn1)P(=O)(O)O","inchiKey":"BNMYZGAZFGNKTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL54714","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03649"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL556937","canonicalSmiles":"O=C(O)CC(O)CC(=O)O","inchiKey":"ZQHYXNSQOIDNTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Hydroxyglutarate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Hydroxyglutarate"],"crossReferences":{"drugbank":["DB04594"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL57","canonicalSmiles":"Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1","inchiKey":"NQDJXKOVJZTUJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NEVIRAPINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nevirapine","Viramune","Viramune xr"],"synonyms":["BIRG 0587","BIRG-0587","NSC-641530","Nevirapine","Nevirapine anhydrous","Viramune"],"crossReferences":{"DailyMed":["nevirapine"],"PubChem":["144207968","170464869","17388862","174006996","26719643","49718173","865943"],"Wikipedia":["Nevirapine"],"drugbank":["DB00238"],"chEBI":["63613"]},"count":6,"approvedIndications":["EFO_0000764","EFO_0000180","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 3 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL577736","canonicalSmiles":"CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O","inchiKey":"NLJVXZFCYKWXLH-DXTIXLATSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TYROTHRICIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bactratycin"],"synonyms":["Tyrothricin"],"crossReferences":{"DrugCentral":["4739"]},"count":1,"approvedIndications":["EFO_1001888"],"description":"Protein drug with a maximum clinical trial phase of IV and is indicated for eye infection."}
{"id":"CHEMBL605846","canonicalSmiles":"COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1","inchiKey":"COUYJEVMBVSIHV-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLODATEROL","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Striverdi respimat"],"synonyms":["BI 1744","Olodaterol"],"crossReferences":{"DailyMed":["olodaterol%20hydrochloride"],"Wikipedia":["Olodaterol"],"drugbank":["DB09080"],"chEBI":["82700"]},"childChemblIds":["CHEMBL2105743"],"count":4,"approvedIndications":["HP_0006536"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0000270","EFO_0000464","EFO_0001421","EFO_0000341"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for airway obstruction and has 3 investigational indications."}
{"id":"CHEMBL607400","canonicalSmiles":"CCC[C@@H]1CC(=O)N([C@@H](CC)C(N)=O)C1","inchiKey":"MSYKRHVOOPPJKU-BDAKNGLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRIVARACETAM","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Briviact"],"synonyms":["Brivaracetam","UCB 34714","UCB-34714"],"crossReferences":{"DailyMed":["brivaracetam"],"Wikipedia":["Brivaracetam"],"drugbank":["DB05541"]},"count":3,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000159164"],"count":1},"linkedDiseases":{"rows":["Orphanet_308","EFO_0000474","EFO_1001919","EFO_0006510","HP_0001250"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for epilepsy and has 2 investigational indications."}
{"id":"CHEMBL64391","canonicalSmiles":"CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O","inchiKey":"VHVPQPYKVGDNFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ITRACONAZOLE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Itraconazole","Onmel","Sporanos","Sporanox","Sporanox i.v.","Sporanox-pulse","Tolsura"],"synonyms":["Itraconazole","Itrazole","R 51,211","R-51211"],"crossReferences":{"DailyMed":["itraconazole"],"PubChem":["104171385","174006588","26663153","26719680","29215099","56422506","855766"]},"count":47,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 47 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL666","canonicalSmiles":"O=C(O)P(=O)(O)O","inchiKey":"ZJAOAACCNHFJAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FOSCARNET","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dihydroxyphosphinecarboxylic Acid Oxide","Foscarnet","J05AD01"],"crossReferences":{"DailyMed":["foscarnet%20sodium"],"Wikipedia":["Foscarnet"],"drugbank":["DB00529"],"chEBI":["127780"]},"childChemblIds":["CHEMBL754","CHEMBL4063154"],"count":4,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for viral disease and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL686","canonicalSmiles":"Cc1cccc(Nc2ccccc2C(=O)O)c1C","inchiKey":"HYYBABOKPJLUIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MEFENAMIC ACID","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Contraflam","Dysman-250","Dysman-500","Mefenamic acid","Meflam 250","Meflam 500","Mendys","Opustan 250","Opustan 500","Ponstan","Ponstan fte","Ponstel"],"synonyms":["CI-473","CN-35355","INF-3355","J2.344B","M01AG01","Mefenamic acid","NSC-94437"],"crossReferences":{"DailyMed":["mefenamic%20acid"],"PubChem":["104171280","11112163","124882006","144203895","144212300","170464813","26746974","26751493","56422190","855723"],"TG-GATEs":["84"],"Wikipedia":["Mefenamic_acid"],"drugbank":["DB00784"],"chEBI":["6717"]},"count":5,"approvedIndications":["HP_0100607","EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["MP_0001914","HP_0100607","EFO_0000400","EFO_0003843","EFO_0005755"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for rheumatic disease and dysmenorrhea and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL7568","canonicalSmiles":"CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12","inchiKey":"GPKJTRJOBQGKQK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINACRINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNF-Pf-5448","Mepacrine","Quinacrine"],"crossReferences":{"PubChem":["124881289","50111199","90341425"],"Wikipedia":["Mepacrine"],"drugbank":["DB01103"],"chEBI":["8711"]},"childChemblIds":["CHEMBL2105615","CHEMBL556980","CHEMBL554190","CHEMBL546257"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL77305","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c([N+](=O)[O-])cccc3nc2-1","inchiKey":"VHXNKPBCCMUMSW-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUBITECAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-nc","RFS 2000","RFS-2000","RFS2000","Rubitecan"],"crossReferences":{"PubChem":["144206150","50113013"],"Wikipedia":["Rubitecan"],"drugbank":["DB06159"],"chEBI":["90225"]},"count":12,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL77921","canonicalSmiles":"Cc1cccc(C(C)c2c[nH]cn2)c1C","inchiKey":"CUHVIMMYOGQXCV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEDETOMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Domitor"],"synonyms":["Medetomidine"],"crossReferences":{"Wikipedia":["Medetomidine"],"drugbank":["DB11428"],"chEBI":["48552"]},"childChemblIds":["CHEMBL537161"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL84617","canonicalSmiles":"CCC(=O)N(c1ccccc1F)C1(c2ccccc2)CCN(CCn2nnn(CC)c2=O)CC1","inchiKey":"RJSCINHYBGMIFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TREFENTANIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trefentanil"],"crossReferences":{"Wikipedia":["Trefentanil"],"drugbank":["DB09181"]},"childChemblIds":["CHEMBL2107275"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL863","canonicalSmiles":"N[C@@H](CS)C(=O)O","inchiKey":"XUJNEKJLAYXESH-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYSTEINE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cysteine","Cysteine HCl","E920","E921"],"crossReferences":{"DailyMed":["cysteine%20hydrochloride"],"drugbank":["DB00151"],"chEBI":["17561"]},"childChemblIds":["CHEMBL1200630"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986."}
{"id":"CHEMBL92636","canonicalSmiles":"Oc1cc2cc[nH]c2cc1O","inchiKey":"SGNZYJXNUURYCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL92636","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01811"],"chEBI":["27404"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL94657","canonicalSmiles":"C/C(=C\\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1","inchiKey":"QXRSDHAAWVKZLJ-PVYNADRNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PATUPILONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EPO 906","EPO 906A","EPO-906","EPO-906A","Epothilone b","GNF-PF-193","Patupilone"],"crossReferences":{"PubChem":["50125842","520207"],"drugbank":["DB03010"],"chEBI":["31550"]},"count":17,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 17 investigational indications."}
{"id":"CHEMBL986","canonicalSmiles":"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1","inchiKey":"FPIPGXGPPPQFEQ-OVSJKPMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RETINOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aquasol a","Arovit","Nepalm","Retinol","Ro-a-vit","Vitamin A 1","Vitamin A Solubilized","Vitamin a"],"synonyms":["NSC-122759","Oleovitamin a","Retinol","Retinol (vit a)","Retinol acetate","Retinol palmitate","Vitamin A","Vitamin a","Vitamin a oil"],"crossReferences":{"DailyMed":["vitamin%20a"],"PubChem":["104171352","124883068","144204369","144209639","144210607","17389530","26747393","26753109","26753110","416404","47193665","50105638"],"TG-GATEs":["59"],"Wikipedia":["Retinol","Vitamin_A"],"drugbank":["DB00162"],"chEBI":["17336"]},"count":11,"approvedIndications":["EFO_0003966","EFO_0003894","HP_0001742"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 8 investigational indications."}
